Description
KLOW is a laboratory-formulated research peptide blend supplied by AusPepLabs, combining four extensively studied research compounds – TB-500 (Thymosin Beta-4), BPC-157, GHK-Cu (Copper Tripeptide-1), and KPV (Lys-Pro-Val) – in a single 80mg lyophilized vial. Building on the GLOW blend with the addition of KPV, KLOW adds a fourth mechanistic dimension covering NF-κB pathway modulation and epithelial barrier biology research models. Each vial is independently verified to ≥99% HPLC purity with a Certificate of Analysis available on request. For scientific research use only.
Why Research Laboratories Select KLOW
KLOW expands on the GLOW blend by adding KPV – a synthetic α-MSH C-terminal tripeptide studied for its cellular uptake via the PepT1 oligopeptide transporter and NF-κB pathway interactions in intestinal epithelial cell models. This fourth component adds an inflammatory signaling and epithelial biology dimension to the three-pathway GLOW system, giving researchers a broader multi-pathway reference tool in a single 80mg lyophilized vial.
- Four-component blend – TB-500, BPC-157, GHK-Cu, and KPV in one 80mg lyophilized vial
- KPV addition – adds NF-κB pathway modulation and epithelial barrier biology to the GLOW framework
- Multi-pathway research system – cytoskeletal, gastrointestinal peptide, copper-dependent, and inflammatory signaling studied simultaneously
- GHK-Cu at 50mg dominant concentration – suited for extracellular matrix and copper-peptide research
- TB-500, BPC-157, and KPV at 10mg each – complementary pathway coverage
- Each component independently verified to ≥99% HPLC purity
- Lyophilized format ensures stability and reproducibility across experimental runs
| TB-500 (10mg) | (CAS 77591-33-4). 43 amino acid synthetic peptide corresponding to Thymosin Beta-4. Studied for actin-binding properties, G-actin sequestration, and cytoskeletal remodeling in preclinical research models. |
| BPC-157 (10mg) | (CAS 137525-51-0). 15 amino acid synthetic pentadecapeptide derived from human gastric juice protein. Studied for nitric oxide pathway interactions and angiogenic signaling in preclinical research models. . |
| GHK-Cu (50mg) | (CAS 49557-75-7). Naturally occurring copper-binding tripeptide (Gly-His-Lys·Cu²⁺). Studied for extracellular matrix signaling, copper-dependent enzymatic activity, and gene expression modulation in cellular research models. |
| KPV (10mg) | (CAS 67727-97-3).Synthetic tripeptide (Lys-Pro-Val) derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH positions 11-13). Studied for NF-κB pathway modulation and epithelial barrier biology in intestinal cell research models. |

Reviews
There are no reviews yet.